DK0941998T3 - 3,6-ketalmakrolidantibiotika - Google Patents

3,6-ketalmakrolidantibiotika

Info

Publication number
DK0941998T3
DK0941998T3 DK99301325T DK99301325T DK0941998T3 DK 0941998 T3 DK0941998 T3 DK 0941998T3 DK 99301325 T DK99301325 T DK 99301325T DK 99301325 T DK99301325 T DK 99301325T DK 0941998 T3 DK0941998 T3 DK 0941998T3
Authority
DK
Denmark
Prior art keywords
ketal
macrolide antibiotics
macrolide
antibiotics
ketal macrolide
Prior art date
Application number
DK99301325T
Other languages
Danish (da)
English (en)
Inventor
Kristin M Lundy
Hengmiao Cheng
Subas M Sakya
Peter Bertinato
Martha L Minich
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK0941998T3 publication Critical patent/DK0941998T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK99301325T 1998-03-03 1999-02-23 3,6-ketalmakrolidantibiotika DK0941998T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7663098P 1998-03-03 1998-03-03

Publications (1)

Publication Number Publication Date
DK0941998T3 true DK0941998T3 (da) 2004-09-20

Family

ID=22133253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99301325T DK0941998T3 (da) 1998-03-03 1999-02-23 3,6-ketalmakrolidantibiotika

Country Status (17)

Country Link
US (1) US6043226A (fr)
EP (1) EP0941998B1 (fr)
JP (1) JP3666788B2 (fr)
CN (1) CN1244532A (fr)
AR (1) AR016715A1 (fr)
AT (1) ATE275151T1 (fr)
AU (1) AU741435B2 (fr)
BR (1) BR9900856A (fr)
CA (1) CA2263203C (fr)
DE (1) DE69919769T2 (fr)
DK (1) DK0941998T3 (fr)
ES (1) ES2226282T3 (fr)
HU (1) HUP9900492A3 (fr)
NO (1) NO312366B1 (fr)
NZ (1) NZ334442A (fr)
PT (1) PT941998E (fr)
ZA (1) ZA991664B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
TR200101241T2 (tr) 1998-11-03 2001-09-21 Pfizer Products Inc. Yeni makrolit antibiyotikler
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6451768B1 (en) * 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
EP1146051A3 (fr) * 2000-04-10 2001-10-31 Pfizer Products Inc. Dérivées de l' érythromycine A
AU2001214707A1 (en) * 2000-11-07 2002-05-21 Morphotek Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060141470A1 (en) * 2003-02-14 2006-06-29 Kalayoglu Murat V Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
UA85937C2 (uk) 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
EP2203435B1 (fr) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. Macrolides à base de biaryle à liaison 6, 11
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
CA3060892A1 (fr) * 2017-04-20 2018-10-25 Rising Tide Foundation Derives d'azithromycine contenant un ion phosphonium utilises en tant qu'agents anticancereux
WO2018193111A1 (fr) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Dérivés d'azithromycine contenant un ion phosphonium utilisés en tant qu'agents anticancéreux
WO2018193126A1 (fr) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Dérivés d'azithromycine contenant un ion phosphonium en tant qu'agents antibactériens
CN110799516A (zh) * 2017-04-20 2020-02-14 来兴泰德基金会 作为抗癌剂的包含鏻离子的阿奇霉素衍生物
WO2018193116A1 (fr) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Dérivés d'azithromycine contenant un ion phosphonium utilisés en tant qu'agents anticancéreux
US11197872B2 (en) 2017-04-21 2021-12-14 Lunella Biotech, Inc. Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
EP3612177A4 (fr) 2017-04-21 2021-01-13 Lunella Biotech, Inc. Ciblage de cellules souches cancéreuses hypoxiques (csc) à l'aide de doxycycline : implications pour améliorer une thérapie anti-angiogénique
PH12019502594A1 (en) 2017-05-19 2020-10-26 Lunella Biotech Inc Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CA3063450A1 (fr) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Diagnostic compagnon pour inhibiteurs mitochondriaux
KR102854338B1 (ko) 2017-06-26 2025-09-03 루넬라 바이오테크 인코포레이티드 미토케토신: 암 세포에서 케톤 대사를 표적화하는 미토콘드리아-기반의 치료제
GB201817083D0 (en) * 2018-10-19 2018-12-05 Novintum Biotechnology Gmbh Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
EP0344106A3 (fr) * 1988-05-24 1990-01-31 Ciba-Geigy Ag Colorants bleus de dispersion et mélanges de colorants bleus de dispersion
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
KR960700258A (ko) * 1993-01-26 1996-01-19 우에하라 아키라 5-0-데소사미닐에리쓰로노라이드 유도체
JP2000509712A (ja) * 1996-05-07 2000-08-02 アボツト・ラボラトリーズ ６―ｏ―置換エリスロマイシン及びその製造方法

Also Published As

Publication number Publication date
NO991012D0 (no) 1999-03-02
PT941998E (pt) 2004-12-31
NO991012L (no) 1999-09-06
US6043226A (en) 2000-03-28
BR9900856A (pt) 2000-04-25
JP3666788B2 (ja) 2005-06-29
JPH11315093A (ja) 1999-11-16
EP0941998B1 (fr) 2004-09-01
ES2226282T3 (es) 2005-03-16
CA2263203C (fr) 2002-09-03
DE69919769T2 (de) 2005-01-27
AU741435B2 (en) 2001-11-29
HUP9900492A2 (hu) 1999-09-28
EP0941998A3 (fr) 1999-10-06
NZ334442A (en) 2000-03-27
CA2263203A1 (fr) 1999-09-03
AU1856299A (en) 1999-09-16
DE69919769D1 (de) 2004-10-07
HUP9900492A3 (en) 2001-08-28
ZA991664B (en) 2000-10-12
EP0941998A2 (fr) 1999-09-15
ATE275151T1 (de) 2004-09-15
NO312366B1 (no) 2002-04-29
CN1244532A (zh) 2000-02-16
AR016715A1 (es) 2001-07-25
HU9900492D0 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
DE69919769D1 (de) 3,6-Ketal-Makrolidantibiotika
IS5528A (is) Ný makrólíð
ATE322910T1 (de) Neuartige antibiotika
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DE69838651D1 (de) Erythromycinderivate
IS5919A (is) Ný makrólíð sýklalyf
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
IS5251A (is) 9-oxím erýþrómýsín afleiður
ATE256694T1 (de) Ketolid-antibiotika
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
NO20010250D0 (no) Nocatiacin-antibiotika
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DK1149106T3 (da) 4,5-azolo-oxindoler
EP0766685A4 (fr) Macrolides aryles, alkyles, alcenyles et alcynyles
ID26368A (id) Turunan-turunan 2 deoksi higromisin
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
FI971952A0 (fi) Antibiotiskt aemne